Cardinal Health (NYSE: CAH) today posted second-quarter results that beat the overall consensus on Wall Street.
The Dublin, Ohio-based company reported losses of $130 million, or 50¢ per share, on sales of $51.5 billion for the three months ended December 31, 2022. Cardinal Health’s results swung to a loss versus the same quarter a year ago. During Q2 2022, it earned $49 million, or 17¢ per share.
Sales in the most recent quarter were up 13%.
Adjusted to exclude one-time items, earnings per share were $1.32, 18¢ ahead of The Street, where analysts were looking for sales of $50.74 billion.
“Our second quarter results demonstrate continued momentum against our plans, led by better-than-expected performance in the Pharmaceutical segment and Medical results in-line with our prior commentary,” CEO Jason Hollar said in a news release. “With the first half of fiscal year 2023 behind us, we are pleased to raise our full-year non-GAAP EPS…